ASTERIAS BIOTHERAPEUTICS INC's ticker is and the CUSIP is 04624N907. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 2 | -96.2% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 53 | -44.2% | 0.00% | – |
| Q3 2017 | $4,000 | -55.6% | 95 | -65.1% | 0.00% | – |
| Q2 2017 | $9,000 | +350.0% | 272 | -5.6% | 0.00% | – |
| Q1 2017 | $2,000 | -60.0% | 288 | +380.0% | 0.00% | – |
| Q4 2016 | $5,000 | -85.7% | 60 | -92.5% | 0.00% | -100.0% |
| Q3 2016 | $35,000 | +118.8% | 795 | +23.3% | 0.00% | +100.0% |
| Q2 2016 | $16,000 | – | 645 | +64400.0% | 0.00% | – |
| Q1 2016 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 200 | $85,000 | 0.00% |
| SIMPLEX TRADING, LLC | 795 | $35,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,000 | $13,000 | 0.00% |